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Specific 125I-endothelin-1 (125I-ET-1) binding sites were investigated in 
the rat eye, using receptor autoradiographic techniques. 125I-ET-1 was 
specifically bound to the rat eye sections, with a slow association rate, 
as evidenced by kinetic experiments. The radioligand binding reached 
a maximum at 48hr of incubation and a plateau was maintained for 
up to 72hr. No degradation of 125I-ET-1 during incubation was 
observed at 72hr. Specific 125I-ET-1 binding sites were localized in 
areas corresponding anatomically to the cornea, the iris, the retina, 
the choroid and the sclera. 125I-ET-1 binding to these sections was 
monophasically inhibited by unlabeled ET-1 with dissociation 
constant (Kd) of 128pM, whereas unlabeled ET-3, a member of the ET 
family peptides, biphasically inhibited binding with low affinity, 
inhibition constant (Ki) of 7.06nM, and high affinity, Ki of 53pM. This 
evidence for specific 125I-ET-1 binding sites supports the physiological 
significance of the ET family peptides in the rat eye.
Introduction 
Endothelin-1 (ET-1) and ET-3, members of the ET family 
peptides"", are functional peptides in the eye regulating 
intraocular pressure, ocular blood vessel tone, and iris 
smooth muscle tone"'. ET-1 gene expression in the rat iris 
was noted using in situ hybridization techniques with a 
radiolabeled ET-1 complementary RNA probes'. ET-1-and 
ET-3-like immunoreactivities were also histochemically 
evident in rabbit ocular areas corresponding anatomically 
to the iris and to the ciliary body". The peptides pre-
sumably exert physiological functions in the eye, by inter-
acting with specific receptors, classified recently as two 
subtypes; the ETA receptor", preferentially recognized by 
ET-1, and the ET, receptor'', a non-selective subtype. 
 Although specific binding sites for 125I-ET-1, candidates 
of physiologically active receptors, have been detected 
within the eye"', much less is known of characteristics of 
the ET receptor in this organ. Using the quantitative recep-
tor autoradiography9' 10) with radioluminography11,12', we 
investigated specific 1251-ET-1 binding sites, candidates of 
physiologically active receptors for the ET family peptides, 
in the rat eye.
Materials and Methods 
Materials 
'25I-ET-1 was purchased from the New England Nuclear, U. 
S. A., and peptides used were from the Peninsula Lab., U. 
S. A. and the Peptide Institute, Japan. Drugs were pur-
chased from the Sigma Chemical Co., U. S. A. Male Wistar 
Kyoto rats weighing 250g were given standard chow (F-2, 
Funabashi Farm Co., Japan) and water ad libitum and were 
housed at 24°C,with lights on from 07:00 hr to 19:00 hr at 
the Laboratory Animal Center for the Biomedical Re-
search, Nagasaki University School of Medicine, Japan. 
The rats were decapitated between 10:00 hr and 12:00 hr 
and eyes were rapidly removed and immediately placed in 
isopentane at -30°C. Frozen, 10-,um-thick eye sections 
were cut in a cryostat at -20'C, thaw-mounted onto gelatin-
coated slides, and stored overnight under vacuum at 4T. 
Quantitative receptor autoradiography 
Tissue sections were labeled in vitro with 125I-ET-1 (spe-
cific activity, -81.4TBq/mmol) in 2.Oml of incubation box 
Briefly, after preincubation at room temperature (23°C) for 
10min in the incubation buffer, consecutive tissue sections 
were incubated at 4°C for 48hr with 32.6pM 1251-ET-1, in 
the absence (total binding) or presence of increasing con-
centrations of unlabeled ET-1 and ET-3, ranging from 
1.OpM to 1.0,u M and 1.0pM to 10,u M, respectively, in 
50mM Tris-HC1 buffer (pH 7.4) containing 100mM NaC1, 
10mM EDTA -2Na, l mg/ml bacitracin, 4,a g/ml leupeptin, 
2,a g/ml chymostatin, 10g M phosphoramidon13' and 0.2% 
(w/v) bovine serum albumin (proteinase-free). Following 
these incubations, the slides were washed 3 times (1 min 
each) at 4°C in 50mM Tris-HC1 buffer (pH7.4), rinsed 
quickly in ice-cold distilled water, and then dried under a 
stream of cold air. 
 To quantitate '25I-ET-1 bound to the sections, we used 
the computerized radioluminographic system with imaging 
plates coated with fine photostimulable phosphor crystals 
(BaFBr:Eu2+)11) These dried, labeled sections were exposed 
to radioluminographic imaging plates (Type BAS-III) with
calibrated 10-/-Lm-thick 125I-standards ([1251] micro-scales, 
Amersham, U. K.). The autoradiograms obtained were 
analyzed using the radioluminergic imaging plates system 
(Bio-imaging Analyzer BAS 2000, Fuji Photo Film Co., 
Japan). The values of photostimulated luminescence (PSL) 
directly obtained from the imaging plates by the comput-
erized scanning system were converted to the bound radio-
activity of the section, based on a comparison with 
standards curves for sets of standards rum on each imaging 
plate"'. After quantitation, the sections labeled with the 
radioligand were also exposed to Hyperfilm-3H (Amer-
sham) to acquire autoradiograms. The films were devel-
oped at 4°C for 7min, with a Kodak D19 developer 
(Eastman Kodak, U. S. A.). 
  In the initial experiment, we investigated the appropriate 
incubation time, under the conditions described above. 
Incubations were carried out at 4°C for 30min, lhr, 2hr, 
6hr, 12hr, 24hr, 36hr, 48hr and 72hr, then the degradation 
of 1251-ET-1 in the incubation buffer was checked using 
high-performance liquid chromatography (HPLC). One 
hundred ,a 1 sample of the incubation buffer with the radio-
ligand was injected onto a HPLC system composed of a 
6000A pump and reverse-phase ,aBondasphere C18 column 
(5,um C,8, 3.9 x 150mm, Waters, U. S. A.). 125I-ET-1 was 
separated using a linear gradient of 20% to 40% (v/v) 
acetonitrile in 0.1% (v/v) trifluoroacetic acid, at a rate of 
1.Oml/min. Fractions of 2.Oml were collected and the radio-
activity was detected by 7-counting. 
Data analysis 
The data obtained by quantitative receptor autoradiographic 
studies were analyzed using the LIGAND computer pro-
gram"". Results were expressed as means ± S. E. Diffe-
rences in the data were assessed by one-way analysis of
variance (ANOVA) using the F test.
Results 
In the initial experiments done at 4°C with 26.7pM 125I-
ET-l, we found that specific 1251-ET-1 binding to the rat eye 
sections reached a maximum at 48 hr, and a plateau was 
maintained for up to 72hr (Fig. 1). The radioligand was 
stable during the 72hr incubation time, as the HPLC anal-
ysis revealed no degradation of 1251-ET-1 in the incubation 
buffer (Fig. 2). Hence, the following binding experiments 
were carried out at 4 °C for 48hr.
Fig. 1. Effect of incubation time on specific binding of t25I-
endothelin-1 (1251-ET-1) to rat eye sections. Each point represents 
the mean of four determinations. Related tissue sections were 
incubated at 4 °C with 26.7pM 121I-ET-1 in the absence or presence 
of 1.O,uM unlabeled ET-1.
Fig. 2. High-performance liquid chromatographic analysis of 1251-endothelin-1 ("I-ET-1) before (A) and after (B) incubation of 72hr at 4 °C . The sample was loaded on a reverse-phase ,uBondasphere C,8 column (3.9 x 150mm) and eluted at 1.0ml/min with a linear gradient 
of 20% to 40% acetonitrile in 0.1% (v / v) trifluoroacetic acid. Fractions of 2.Oml were collected and the radioactivity was detected by 
-r -counting.
 Autoradiographic localization of "'I-ET-1 binding sites              ET-1 
in the rat eye is shown in Fig. 3. '25I-ET-1 richly labeled the 
cornea, the iris, the retina and the area anatomically corre-
sponding to the choroid and the sclera (Fig. 3A). This 
localization is in accord with the findings of Koseki et al. 
(1989)8) and MacCumber et al. (1989)5'. Apparent specific 
binding concentrationes were calculated by subtracting 
non-specific binding concentrationes obtained at incubation 
with 32.6pM 125I-ET-1 in the precence of 1.01- LM ET-1 
from total binding concentrations (Table 1). The highest 
densities were observed in the iris and the area of the 
choroid and the sclera Binding sites in the retina were 
divided into two areas, inner and outer parts, with high and 
moderate densities, respectively. A moderate density of 
binding was noted in the cornea. Unlabeled ET-1 at a 
concentration of 1.O/1M completely inhibited 1251-ET-1 
binding to various areas, with the exception of the lens. 12'I-
    slightly bound to the lens, however, the binding was 
not inhibited by 1.0,aM ET-1 (Fig. 3B). We also calculated 
specific binding concentrations of 125I-ET-1 remaining in 
the presence of lO,uM ET-3. As shown in Table 1, interest-
ingly, ET-3 most potently inhibited binding to the cornea. 
In this area, binding concentrations ramained at the pres-
ence of an excess amount, l0,u M, of ET-3 was only 5.0% 
of specific binding concentration obtained in case of incu-
bation with 32.6pM 1251-ET-1. The peptide significantly 
inhibited binding to the iris and to the inner part of the 
retina, but 6.8% and 14.5% of specific binding remained, 
respectively. ET-3 was the weakest inhibitor for 125I-ET-1 
binding to the outer part of the retina, and the area anato-
mically corresponding to the choroid and the sclera. 
  125I-ET-1 binding characteristics were examined in a 
cold ligand-saturation study using rat whole eye sections in 
the presence of a fixed amount of 1251-ET-1 (32.6pM) and
Fig. 3. Receptor autoradiographic localization of 125I-endothelin-1 binding sites in the rat eye. Consecutive, 10-,am-thick sections were 
labeled with 32.6pM 125I-ET-1 in the absence (total binding, A) or presence of 1.0,aM ET-1 (non-specific binding, B), in vitro. After 
incubation dried sections were exposed to Hyperfilm-'H for 2 days. RETINA (a), inner part of the retina; RETINA (b), outer part of the 
retina; TB, total binding. Bar = 2.0mm.
Table 1. Specific binding concentrations (SB) of t25I-endothelin-1 (32.6pM) and binding concentrations in the presence of 10,aM 
endothelin-3 (ET-3) in the rat eye. These binding concentrations (fmol/mg) were calculated by subtracting non-specific binding 
concentrations obtained at incubation with the radioligand in the presence of 1.0,aM endothelin-1 (ET-1) from total binding 
concentrations. The ratio (%) of values of binding concentrations remained in the presence of ET-3 to SB was slso calculated (ET-3/SB). 
Values were expressed as means ± S. E. of three rats.
                      cornea iris inner retina outer retina choroid + sclera 
 SB 16.5±0.48 34.5±3.6b 28.3±0.7` 15.5±11d 31.0±2.4` 
 ET-3 0.9 ± 0.0 3.1 ± 0.4 4.1 ± 0.4 4.4 ± 0.1 6.9 ± 0.5 
 ET-3/SB 5.0±0.3` 6.8±018 14.5±2.7h 22.0±2.7 30.7±3.1' 
 ET-1 0.2 ( ± 0.03) 0.7( ± 0.02) 0.8 ( ± 0.08) 0.2 ( ± 0.02) 0.7 ( ± 0.04) 
Significant differences among the SB. P < 0.05 (a < b, F = 22.49), P < 0.01 (d < b, F = 25.16). 
Significant differences among the ET-3/SB (%). P < 0.01 (f < g, F = 26.63; f < h, F = 57.34; f < i, F = 39.77; f < j, F = 67.38; g < h, 
F=40.41;g<i,F=32.45;g<j,F=58.91;h<j,F=23.64.
increasing concentrations of unlabeled ET-1, ranging from 
1.0pM to 1.0,u M (Fig. 4 and Table 2). 125I-ET-1 binding to 
the eye sections was monophasically inhibited by unlabeled 
ET-1 with a high affinity, as evidenced by the straight line 
in the Scatchard plot. We used ET-3 as an inhibitor to 
characterize 125I-ET-1 binding sites in the rat eye, since a 
comparison of the potencies of ET-1 and ET-3 at inhibiting 
125I-ET-1 binding discriminates between multiple endothelin 
receptors';". The inhibition curve obtained with ET-3 was 
bimodal. Scatchard analysis of the data obtained with the 
program LIGAND indicated the presence of a low-affinity 
site with an inhibition constant (K) of 7.06nM for ET-3, 
and a high affinity-site with a K; of 53pM. Thus, the 
binding characteristics suggested that the receptors, ETA 
and ETB are present in the rat eye.
Fig. 4. Cold-ligand saturation and displacement experiments of '25I-endothelin-1 (125I-ET-1) binding to rat eye sections. Consec-
utive tissue sections were incubated with 32.6pM 125I-ET-1 in the 
absence or presence of increasing concentrations of unlabeled 
ET-1 (0) or ET-3 (0 ). A typical Scatchard plot (inner part in 
the figure) was obtained by displacing the binding of 32.6pM 125I-
ET-1 by unlabeled ET-1 (0 ), by using the LIGAND computer 
program.
Table 2. Binding parameters obtained from cold-ligand satura-
tion and displacement experiment done for endothelin-1 and 
endothelin-3, respectively; dissociation constant (K6), maximum 
binding capacity (B,,,,,,), and inhibition constant (K;) of specific 125I-
endothelin-1 binding sites in the rat eye. Values are expressed as 
means ± S. E. of three rats.
              Kd B„ K, (PM) 
           (PM) (fmol/mg) high low 
rat whole eye 128± 11 189±79 53± 10 7060±2018 
Data were analyzed using the program LIGAND.
Disscussion 
ETs are biologically active peptides functioning within the 
eye and we investigated the localization and character-
ization of the specific 125I-ET-1 binding sites. A comparison 
between localization of the receptors presented here and 
mRNAs encoding endothelin receptors reported by Mac-
Cumber et al. (1989)5' seems pertinent to the functional 
significance of the ET family peptides within the eye. 
Accumulating evidence revealed that the ET family pep-
tides function as mediators in autocrinal and paracrinal 
systems"''. The receptors and the production system coexist 
in the iris, whereas the cornea and the choroid seem to 
possess only the receptors. Thus, a paracrinal system may 
function to regulate the pupil size in the iris'-`,`,", and an 
autocrinal system equipped with the ETB receptor seems to 
operate in the cornea. 
 Based on the binding characteristics obtained in dis-
placement studies, we postulate that the two endothelin 
receptors, the ETA receptor", preferentially recognized by 
ET-1 with a much higher affinity than by ET-3, and the 
ETB receptor'', which is bound by ET-1, ET-2 and ET-3 
with the same affinity, exist within the rat eye. Of particular 
interest was our observation that there was a difference 
between the potencies of 10/i M ET-3 at inhibiting 125I-
ET-1 binding to different rat eye areas. As ET-3 almost 
fully inhibited specific binding to the cornea, it may be that 
the cornea mainly carries the ETB receptor. Based on 
findings using in situ hybridization techniques, Hori et al."' 
reported that mRNA encoding the rat ETB receptor is 
widely distributed in various endothelial cells and regulates 
water and electrolyte permeability in epithelial cells of the 
choroid plexus, ependymal cells lining the ventricle and 
renal endothelial cells of the glomerulus, the vasa recta 
bundle and thin segments of Henle's loop. Taken together 
with findings that ET-1 inhibited Na+, K+-ATPase in the 
tubular epithelial cells of the renal collecting duct"' and 
cultured rat vascular smooth muscle cells"', the possibility 
that ET family peptides play a function related to osmotic 
control between the anterior chamber and the corneal 
stroma by interacting with the ETB receptor would have to 
be considered. As the astrocytic ETB receptor has a func-
tion in proliferation of its own cells"', our finding that the 
ETB receptor is apparently present in the cornea serves to 
elucidate the regulatory roles of ET family peptides in the 
eye. 
  In areas such as the iris and the choroid, with their dense 
vascular components, we observed a lesser degree of 
potency of ET-3 in inhibiting 125I-ET-1 binding. The ETA 
receptor expressed in vascular smooth muscle cells"' may 
contribute to inhibiting the potency of ET-3. There seems 
to be two subtypes of endothelin receptors in these areas, 
however, the presence and the proportion of the ET,, and 
ETB receptors remains speculative until more is learned of 
1251-ET-1 binding characteristics . 
 The existence of specific 1251-ET-1 binding sites in the 
retina was of particular interest. Although we did not 
observe the cellular localization of the endothelin receptors 
within part of the sensory retina, because of limitations in
the power of resolution of our technique, nevertheless, as 
neuronal cells such as rod bipolar, cone bipolar, bipolar and 
horizontal cells are present in the sensory retina, the finding 
of these receptors in this special area paves the way toward 
elucidation of the neuronal significance of ET family 
peptides. 
 We found in kinetic experiments carried as a function of 
incubation time that 125I-ET-1 specifically bound to rat eye 
sections reached a maximum at 48hr and a plateau was 
maintained for up to 72hr at 4°C, under the conditions 
described. This slow association differs from findings 
obtained using partially purified membrane materials where 
125I-ET-1 reached a maximum within 3h e3, 24, 2S, 26, 27) We 
added phosphoramidon13', an inhibitor of endothelin metab-
olizing neutral endopeptidase (EC 3.4.24.11) to the incu-
bation buffer to prevent the radioligand from degradation 
during a long incubation time. A similar slow association 
was obtained in the case of 125I-ET-1 binding to rat brain 
sections done using receptor autoradiographic technique 
with incubation time of 24hr at 4 °C28'. 
 In summary, we obtained evidence to support the idea 
that ET family peptides function in the rat eye as autocrinal 
and paracrinal transmitters. Although ETA and ETB recep-
tors are apparently present in rat eyes, the precise hetero-
geneity and cellular localization of the receptors remain to 
be elucidated.
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